Molecular Diagnostics Market: Trends and Opportunities

Table of Contents

1. Molecular Diagnostics: An Overview

• 1.1 An Introduction to Molecular Diagnostics
• 1.2 Industry Background
• 1.3 IVD Market: An Analysis

2. Molecular Diagnostics: Market Analysis

• 2.1 Market Size and Growth
• 2.2 Segment Analysis

3. Market Opportunities

• 3.1 HPV - a potential growth opportunity
• 3.2 India - an emerging market for molecular diagnostics
• 3.3 HCV segment - a major contributor to MDx growth

4. Growth Drivers

• 4.1 High returns on investment (ROI)
• 4.2 Growth in US cancer molecular diagnostics market
• 4.3 Macro-environment favoring genetic testing industry
• 4.4 Applied Testing Market
• 4.5 Growth potential in sepsis diagnosis

5. Market Trends

• 5.1 Higher price of MDx compared to traditional tests
• 5.2 Growth of automation solutions
• 5.3 Leading molecular tests conducted in the US
• 5.4 Reimbursement for molecular diagnostics tests?
• 5.5 Blood screening and STD market
• 5.6 Multiplex Platforms

6. Competition

7. Company Analysis

• 7.1 Roche Diagnostics
  • 7.1.1 Company Description
  • 7.1.2 Sales Analysis
  • 7.1.3 Business Strategies
• 7.2 Qiagen
  • 7.2.1 Company Description
  • 7.2.2 Sales Analysis
  • 7.2.3 Business strategies
• 7.3 Abbott
  • 7.3.1 Company Description
  • 7.3.2 Sales Analysis
  • 7.3.3 Business Strategies
• 7.4 GenProbe
  • 7.4.1 Company Description
  • 7.4.2 Sales Analysis
  • 7.4.3 Business Strategies

8. Market Outlook

• 8.1 Market Forecast
• 8.2 Forecast Methodology
  • 8.2.1 Dependent and Independent Variables
  • 8.2.2 Correlation Analysis
  • 8.2.3 Regression Analysis

List of Figures

• Figure 1.1: In Vitro Diagnostic (IVD) Segments
• Figure 1.2: Global IVD Market Size - 2006 - 2008 & 2012E
• Figure 1.3: IVD Market - Region-wise Breakup (2008)
• Figure 1.4: IVD Market - Segment Breakup (2008)
• Figure 1.5: Segment-wise Global IVD Market Growth, 2007-2012E
• Figure 1.6: CAGR of Global IVD Market segments, 2004-2009E
• Figure 2.1: Global Molecular Diagnostics Market Size: 2005 - 2008
• Figure 2.2: Molecular Diagnostics Segment Breakup-Value: 2008
• Figure 2.3: Molecular Diagnostics Segment Breakup-Percentage: 2008
• Figure 3.1: Global HPV market Size (Value): 2003-2008
• Figure 3.2: Global HPV market Size (Value) Forecast: 2009-2015
• Figure 3.3: Global HPV market Potential by Region
• Figure 3.4: Global HPV screening market by region - Penetrated and un-penetrated
• Figure 3.5: Cancer: Incidence & Deaths - US (2008)
• Figure 3.6: Indian molecular diagnostics market: 2007 - 2009
• Figure 4.1: US Cancer Molecular Diagnostics Market: 2006-2012
• Figure 4.2: Incidence and mortality - severe sepsis
• Figure 4.3: Sales potential of sepsis tests
• Figure 5.1: Molecular diagnostics versus traditional tests - Cost comparison
• Figure 5.2: Top-10 Molecular Tests - US
• Figure 6.1: Market share of leading Players - Global IVD Market: 2008
• Figure 6.2: Global Molecular Diagnostics Market Share: Companies - 2008
• Figure 6.3: US Molecular Diagnostics Market Share: Companies- 2007 vs. 2008
• Figure 7.1: Roche Diagnostics - Sales by sub-segment: 2008
• Figure 7.2: Qiagen - Sales by product group (2008)
• Figure 7.3: Abbott - Sales by business segment (2008)
• Figure 7.4: GenProbe - Sales: Clinical Diagnostics & Blood Screening: 2006-08
• Figure 8.1: Global Molecular Diagnostics Market Forecast: 2000 - 2010

List of Tables

• Table 1.1: IVD market by Technology
• Table 8.1 Dependent & Independent Variables (2002- 2008)
• Table 8.2 Correlation Matrix
• Table 8.3 Model Summary - Coefficient of Determination
• Table 8.4 Regression Coefficients Output